...
首页> 外文期刊>Cancer Medicine >Prognostic significance of Daxx NCR (Nuclear/Cytoplasmic Ratio) in gastric cancer
【24h】

Prognostic significance of Daxx NCR (Nuclear/Cytoplasmic Ratio) in gastric cancer

机译:Daxx NCR(核/细胞质比)在胃癌中的预后意义

获取原文

摘要

Abstract In addition to regulating apoptosis via its interaction with the death domain of Fas receptor, death domain associated protein 6 (Daxx) is also known to be involved in transcriptional regulation, suggesting that the function of Daxx depends on its subcellular localization. In this study, we aimed to explore Daxx subcellular localization in gastric cancer (GC) cells and correlate the findings with clinical data in GC patients. Seventy pairs of tissue samples (GC and adjacent normal tissue) were analyzed immunohistochemically for Daxx expression and localization (nuclear and cytoplasmic). The Daxx Nuclear/Cytoplasmic ratio (Daxx NCR) values in tissue microarray data with 522 tumor samples were further analyzed. The defined Prior cohort ( n = 277, treatment between 2006 and 2009) and Recent cohort ( n = 245, treatment between 2010 and 2011) were then used to examine the relationship between Daxx NCR and clinical data. The Daxx NCR was found to be clinically informative and significantly higher in GC tissue. Using Daxx NCR (risk ratio = 2.0), both the Prior and Recent cohorts were divided into high- and low-risk groups. Relative to the low-risk group, the high-risk patients had a shorter disease free survival (DFS) and overall survival (OS) in both cohorts. Importantly, postoperative chemotherapy was found having differential effect on high- and low-risk patients. Such chemotherapy brought no survival benefit, (and could potentially be detrimental,) to high-risk patients after surgery. Daxx NCR could be used as a prognosis factor in GC patients, and may help select the appropriate population to benefit from chemotherapy after surgery.
机译:摘要死亡结构域相关蛋白6(Daxx)除了通过与Fas受体的死亡结构域相互作用来调节细胞凋亡外,还参与转录调控,这表明Daxx的功能取决于其亚细胞定位。在这项研究中,我们旨在探索胃癌(GC)细胞中的Daxx亚细胞定位,并将该发现与GC患者的临床数据相关联。免疫组织化学分析了七十对组织样本(GC和邻近的正常组织)的Daxx表达和定位(核和细胞质)。进一步分析了具有522个肿瘤样本的组织微阵列数据中的Daxx核/细胞质比(Daxx NCR)值。然后,使用定义的既往队列(n = 277,2006年至2009年之间的治疗)和近期队列(n = 245,2010年至2011年之间的治疗)来检查Daxx NCR与临床数据之间的关系。发现Daxx NCR具有临床信息,在GC组织中明显更高。使用Daxx NCR(风险比= 2.0),既往队列和最近队列均分为高风险和低风险组。相对于低风险组,两个队列中的高风险患者的无病生存期(DFS)和总体生存期(OS)较短。重要的是,发现术后化疗对高危和低危患者有不同的作用。这种化学疗法对高危患者术后没有生存益处,并且可能有害。 Daxx NCR可以用作GC患者的预后因素,并可以帮助选择合适的人群以从术后化疗中受益。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号